查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1541709

2024-2032 年按治疗类型（输血、药物治疗、骨髓移植）、最终用户（医院、诊断中心等）和地区分類的镰状细胞疾病治疗市场报告

Sickle Cell Disease Treatment Market Report by Treatment Type (Blood Transfusion, Pharmacotherapy, Bone Marrow Transplant), End User (Hospitals, Diagnostic Centers, and Others), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

2023年，全球IMARC Group状细胞疾病治疗市场规模达到35亿美元。

镰状细胞疾病 (SCD) 是一种遗传性红血球 (RBC) 疾病，会影响血红蛋白，血红蛋白是一种将氧气输送到全身的蛋白质。它会导致许多併发症，例如急性胸部综合症、贫血和血管闭塞危象（VOC）。目前，医生普遍建议进行血液和骨髓移植来治疗SCD。它涉及用捐赠者提供的健康替代品替换受影响的骨髓。其他有效的治疗方法，例如药物和输血，也正在使用，因为它们可以减轻特定症状并延长患者的生命。

患有 SCD 的人数大幅增加是影响对能够有效治疗这种疾病的新药物需求的重要因素之一。因此，许多国家的卫生监管机构都将重点放在新治疗方法的快速批准上。例如，美国食品药物管理局 (USFDA) 于 2019 年批准了一种新药，用于减轻患有 SCD 的成人和儿童所经历的疼痛。此外，政府当局正在支持研究和开发（R＆D）活动，以鼓励研究人员和製药公司开发新的治疗方法。例如，美国国家心肺血液研究所 (NHLBI) 的研究人员正在研究基因疗法，可以恢復缺失的基因或添加新的 DNA 菌株来改善细胞功能。这些创新，加上可支配收入的增加以及个人对可用医疗服务的认识不断增强，预计将有助于市场成长。

本报告回答的关键问题

  • 2023年全球镰状细胞疾病治疗市场规模有多大？ 2024-2032年全球镰状细胞疾病治疗市场的预期成长率是多少？
  • COVID-19 对全球镰状细胞疾病治疗市场有何影响？
  • 推动全球镰状细胞疾病治疗市场的关键因素是什么？
  • 根据治疗类型，全球镰状细胞疾病治疗市场的细分情况如何？
  • 基于最终用户的全球镰状细胞疾病治疗市场的细分情况如何？
  • 全球镰状细胞疾病治疗市场的关键区域有哪些？
  • 全球镰状细胞疾病治疗市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球镰状细胞疾病治疗市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依治疗类型

  • 输血
    • 市场趋势
    • 市场预测
  • 药物治疗
    • 市场趋势
    • 市场预测
  • 骨髓移植
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：按最终用户

  • 医院
    • 市场趋势
    • 市场预测
  • 诊断中心
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 9 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 10 章：价值链分析

第 11 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 12 章：价格分析

第13章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • AstraZeneca Plc
    • Baxter International Inc.
    • bluebird bio Inc.
    • Bristol-Myers Squibb Company
    • CRISPR Therapeutics
    • Emmaus Medical Inc.
    • Global Blood Therapeutics Inc.
    • GlycoMimetics Inc.
    • Novartis AG
    • Pfizer Inc.
    • Sangamo Therapeutics
Product Code: SR112024A4076

The global sickle cell disease treatment market size reached US$ 3.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.9 Billion by 2032, exhibiting a growth rate (CAGR) of 14% during 2024-2032.

Sickle cell disease (SCD) is a genetic red blood cell (RBC) disorder that affects hemoglobin, a protein that carries oxygen throughout the body. It leads to many complications, such as acute chest syndrome, anemia, and vaso-occlusive crisis (VOC). At present, blood and bone marrow transplant is commonly suggested by doctors for treating SCD. It involves replacing affected bone marrow with a healthy substitute received from a donor. Other effective treatments, such as medications and blood transfusions, are also being utilized as they can reduce specific symptoms and prolong the life of patients.

A considerable increase in the number of individuals suffering from SCD represents one of the significant factors influencing the demand for new medications that can treat the condition effectively. As a result, the health regulatory authorities of numerous countries are focusing on fast-track approval of new treatment methods. For instance, the United States Food and Drug Administration (USFDA) approved a new medicine in 2019 to reduce the pain experienced by adults and children with SCD. Additionally, government authorities are supporting research and development (R&D) activities to encourage researchers and pharmaceutical companies to develop novel treatments. For instance, researchers at the National Heart, Lung, and Blood Institute (NHLBI) in the US are working on genetic therapies that can restore a missing gene or add a new DNA strain to improve the functioning of cells. These innovations, along with the rising disposable incomes and the growing awareness among individuals about the available healthcare services, are anticipated to contribute to market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global sickle cell disease treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on treatment type and end user.

Breakup by Treatment Type:

Blood Transfusion

Pharmacotherapy

Bone Marrow Transplant

Breakup by End User:

Hospitals

Diagnostic Centers

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AstraZeneca Plc, Baxter International Inc., bluebird bio Inc., Bristol-Myers Squibb Company, CRISPR Therapeutics, Emmaus Medical Inc., Global Blood Therapeutics Inc., GlycoMimetics Inc., Novartis AG, Pfizer Inc. and Sangamo Therapeutics.

Key Questions Answered in This Report

  • 1. What was the size of the global sickle cell disease treatment market in 2023?
  • 2. What is the expected growth rate of the global sickle cell disease treatment market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global sickle cell disease treatment market?
  • 4. What are the key factors driving the global sickle cell disease treatment market?
  • 5. What is the breakup of the global sickle cell disease treatment market based on the treatment type?
  • 6. What is the breakup of the global sickle cell disease treatment market based on the end user?
  • 7. What are the key regions in the global sickle cell disease treatment market?
  • 8. Who are the key players/companies in the global sickle cell disease treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Sickle Cell Disease Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Treatment Type

  • 6.1 Blood Transfusion
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Pharmacotherapy
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Bone Marrow Transplant
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by End User

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Diagnostic Centers
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 AstraZeneca Plc
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Baxter International Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 bluebird bio Inc.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Bristol-Myers Squibb Company
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 CRISPR Therapeutics
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Emmaus Medical Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Global Blood Therapeutics Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
    • 13.3.8 GlycoMimetics Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
    • 13.3.9 Novartis AG
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Pfizer Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Sangamo Therapeutics
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Sickle Cell Disease Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Sickle Cell Disease Treatment Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Sickle Cell Disease Treatment Market: Breakup by Treatment Type (in %), 2023
  • Figure 5: Global: Sickle Cell Disease Treatment Market: Breakup by End User (in %), 2023
  • Figure 6: Global: Sickle Cell Disease Treatment Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Sickle Cell Disease Treatment (Blood Transfusion) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Sickle Cell Disease Treatment (Blood Transfusion) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Sickle Cell Disease Treatment (Pharmacotherapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Sickle Cell Disease Treatment (Pharmacotherapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Sickle Cell Disease Treatment (Bone Marrow Transplant) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Sickle Cell Disease Treatment (Bone Marrow Transplant) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Sickle Cell Disease Treatment (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Sickle Cell Disease Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Sickle Cell Disease Treatment (Diagnostic Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Sickle Cell Disease Treatment (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Sickle Cell Disease Treatment (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Sickle Cell Disease Treatment (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: North America: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: North America: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: United States: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: United States: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Canada: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Canada: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Asia-Pacific: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Asia-Pacific: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: China: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: China: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Japan: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Japan: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: India: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: India: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: South Korea: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: South Korea: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Australia: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Australia: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Indonesia: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Indonesia: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Others: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Others: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Europe: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Europe: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Germany: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Germany: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: France: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: France: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: United Kingdom: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: United Kingdom: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Italy: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Italy: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Spain: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Spain: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Russia: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Russia: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Others: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Others: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Latin America: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Latin America: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Brazil: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Brazil: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Mexico: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Mexico: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Others: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Others: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Middle East and Africa: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Middle East and Africa: Sickle Cell Disease Treatment Market: Breakup by Country (in %), 2023
  • Figure 67: Middle East and Africa: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Global: Sickle Cell Disease Treatment Industry: SWOT Analysis
  • Figure 69: Global: Sickle Cell Disease Treatment Industry: Value Chain Analysis
  • Figure 70: Global: Sickle Cell Disease Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Sickle Cell Disease Treatment Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Sickle Cell Disease Treatment Market Forecast: Breakup by Treatment Type (in Million US$), 2024-2032
  • Table 3: Global: Sickle Cell Disease Treatment Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 4: Global: Sickle Cell Disease Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Sickle Cell Disease Treatment Market: Competitive Structure
  • Table 6: Global: Sickle Cell Disease Treatment Market: Key Players